GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACAD
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ACADIA Pharmaceuticals Inc. stock price ended at $16.82 on Friday, after losing 1.46%.
(Updated on Apr 19, 2024)

Sell candidate since Mar 05, 2024 Loss -29.36% PDF

The ACADIA Pharmaceuticals Inc. stock price fell by -1.46% on the last day (Friday, 19th Apr 2024) from $17.07 to $16.82. During the last trading day the stock fluctuated 4.06% from a day low at $16.62 to a day high of $17.30. The price has fallen in 7 of the last 10 days and is down by -6.61% for this period. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $46.79 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -39.60% during the next 3 months and, with a 90% probability hold a price between $8.87 and $11.44 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACAD Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ACADIA Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $17.09 and $19.19. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -36.19%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for ACADIA Pharmaceuticals Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.675 between high and low, or 4.06%. For the last week, the stock has had daily average volatility of 2.87%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACAD) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect ACADIA Pharmaceuticals Inc. to open at $16.91, and during the day (based on 14 day Average True Range), to move between $16.17 and $17.47, which gives a possible trading interval of +/-$0.648 (+/-3.85%) up or down from last closing price. If ACADIA Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 7.71% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $18.48, some $1.66 (9.87%) from the current price of $16.82, our system finds the risk reward not very attractive.

Is ACADIA Pharmaceuticals Inc. stock A Buy?

ACADIA Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.147 Sell Candidate Unchanged

Predicted Opening Price for ACADIA Pharmaceuticals Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$16.91 ( 0.545%) $16.82

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACAD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.59 4.56 %
R2 17.33 3.03 %
R1 17.17 2.08 %
Current price: 16.82
Support S1 16.65 -0.99 %
S2 16.49 -1.94 %
S3 16.24 -3.47 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 19.98 18.79 %
R2 18.73 11.36 %
R1 18.48 9.87 %
Current price 16.82
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for ACADIA Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for ACADIA Pharmaceuticals Inc. is ACAD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ACADIA Pharmaceuticals Inc. Stock?
ACADIA Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ACADIA Pharmaceuticals Inc. Stock?
ACADIA Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ACADIA Pharmaceuticals Inc. Stock.

What's the current price of ACADIA Pharmaceuticals Inc. Stock?
As of the end of day on the 2024-04-19, the price of an ACADIA Pharmaceuticals Inc. (ACAD) share was $16.82.

What is the 52-week high and low for ACADIA Pharmaceuticals Inc. Stock?
The 52-week high for ACADIA Pharmaceuticals Inc. Stock is $33.91 and the 52-week low is $16.60.

What is the market capitalization of ACADIA Pharmaceuticals Inc. Stock?
As of the 2024-04-19, the market capitalization of ACADIA Pharmaceuticals Inc. is 2.771B.

When is the next earnings date for ACADIA Pharmaceuticals Inc.?
The upcoming earnings date for ACADIA Pharmaceuticals Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT